Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Romão

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|January 11, 2024
Immunotherapy in Elderly Patients-Single-Center ExperienceMaria João Ramos, Ana Sofia Mendes, Raquel Romão, et al.
Frontiers in Microbiology|March 30, 2019
IncX4 Plasmid Carrying the New <i>mcr-1.9</i> Gene Variant in a CTX-M-8-Producing <i>Escherichia coli</i> Isolate Recovered From SwineVera Manageiro, Lurdes Clemente, Raquel Romão, et al.
Thoracic Cancer|December 20, 2022
Chemotherapy: A partnership with immunotherapy in non-small cell lung cancerAna Sofia Mendes, Raquel Romão, Joana Febra, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University CenterJoão Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Frontiers in Microbiology|December 13, 2018
Molecular Epidemiology and Risk Factors of Carbapenemase-Producing <i>Enterobacteriaceae</i> Isolates in Portuguese Hospitals: Results From European Survey on Carbapenemase-Producing <i>Enterobacteriaceae</i> (EuSCAPE)Vera Manageiro, Raquel Romão, Inês Barata Moura, et al.
Cancers|December 23, 2022
Best Supportive Care of the Patient with Oesophageal CancerRita Carrilho Pichel, Alexandra Araújo, Vital Da Silva Domingues, et al.
Cancers|February 11, 2023
Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature ReviewRaquel Romão, Ana S Mendes, Ridhi Ranchor, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 6, 2025
Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancerJoão Queirós Coelho, Beatriz Lau, Rita Pichel, et al.
Cancers|June 26, 2025
Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese PopulationLuísa Soares Miranda, Maria João Sousa, Miguel Martins Braga, et al.
Cureus|March 10, 2026
NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast CancerLaura Pratas Guerra, Rafael Sá E Silva, Joana Simões, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|January 11, 2024
Immunotherapy in Elderly Patients-Single-Center ExperienceMaria João Ramos, Ana Sofia Mendes, Raquel Romão, et al.
Frontiers in Microbiology|March 30, 2019
IncX4 Plasmid Carrying the New <i>mcr-1.9</i> Gene Variant in a CTX-M-8-Producing <i>Escherichia coli</i> Isolate Recovered From SwineVera Manageiro, Lurdes Clemente, Raquel Romão, et al.
Thoracic Cancer|December 20, 2022
Chemotherapy: A partnership with immunotherapy in non-small cell lung cancerAna Sofia Mendes, Raquel Romão, Joana Febra, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Vitiligo-like Lesions as a Predictor of Response to Immunotherapy in Non-Small Cell Lung Cancer: Comprehensive Review and Case Series from a University CenterJoão Queirós Coelho, Raquel Romão, Maria João Sousa, et al.
Frontiers in Microbiology|December 13, 2018
Molecular Epidemiology and Risk Factors of Carbapenemase-Producing <i>Enterobacteriaceae</i> Isolates in Portuguese Hospitals: Results From European Survey on Carbapenemase-Producing <i>Enterobacteriaceae</i> (EuSCAPE)Vera Manageiro, Raquel Romão, Inês Barata Moura, et al.
Cancers|December 23, 2022
Best Supportive Care of the Patient with Oesophageal CancerRita Carrilho Pichel, Alexandra Araújo, Vital Da Silva Domingues, et al.
Cancers|February 11, 2023
Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients' Survival: Single Center Experience and Literature ReviewRaquel Romão, Ana S Mendes, Ridhi Ranchor, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 6, 2025
Predictive score for response to neoadjuvant chemotherapy in early-stage HR + /HER2- breast cancerJoão Queirós Coelho, Beatriz Lau, Rita Pichel, et al.
Cancers|June 26, 2025
Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese PopulationLuísa Soares Miranda, Maria João Sousa, Miguel Martins Braga, et al.
Cureus|March 10, 2026
NeoProspect HER2-low: Response and Prognosis After Neoadjuvant Treatment in Patients with HER2-low Breast CancerLaura Pratas Guerra, Rafael Sá E Silva, Joana Simões, et al.
Pageof 2